4//SEC Filing
Rousseau Raphael 4
Accession 0001567619-21-001343
CIK 0001656634other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:11 PM ET
Size
14.6 KB
Accession
0001567619-21-001343
Insider Transaction Report
Form 4
Rousseau Raphael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-01-19$0.76/sh+20,000$15,200→ 20,000 total - Exercise/Conversion
Common Stock
2021-01-20$0.76/sh+10,000$7,600→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-19−20,000→ 135,326 totalExercise: $0.76Exp: 2027-05-17→ Common Stock (20,000 underlying) - Sale
Common Stock
2021-01-19$17.53/sh−20,000$350,564→ 0 total - Sale
Common Stock
2021-01-20$25.07/sh−10,000$250,705→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-20−10,000→ 125,326 totalExercise: $0.76Exp: 2027-05-17→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $15.00 to $20.04 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $25.00 to $25.17 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The stock option vests and becomes exercisable with respect to 25% of the total number of shares on April 17, 2018. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
Related Parties
1- filerCIK 0001754287
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 5:11 PM ET
- Size
- 14.6 KB